Top Markets
#1 DogBull DogBull +55.29%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +31.82%
#3 Siren Siren +30.75%
#4 Purr Purr +19.29%
#5 DigiByte DigiByte +17.88%
#6 OriginTrail OriginTrail +16.28%
#7 龙虾 (Lobster) 龙虾 (Lobster) +12.34%
#8 Ethena Staked ENA Ethena Staked ENA +11.62%
#9 Wrapped XPL Wrapped XPL +10.75%
#10 Plasma Plasma +10.71%
Coin of the day
DogBull DogBull
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Shine-On BioMedical Co.,Ltd. Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd.

6926
Clasificación en acciones #21821
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and... Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Precio por acción
$2.00
Última sincronización: 2026-08-20
Capitalización bursátil
$99.77M
Cambio (1 día)
-0.47%
Cambio (1 año)
-15.35%
País
TW
Comercio Shine-On BioMedical Co.,Ltd. (6926)

Categoría

Healthcare
Ganancias de Shine-On BioMedical Co.,Ltd. (6926)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Shine-On BioMedical Co.,Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Shine-On BioMedical Co.,Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH